Abstract:
The present invention provides methods and compositions to reduce binding of fibrinogen to the ClfA in a gram positive bacterial infections using monoclonal antibody, a polyclonal antibody, an antigen-binding antibody fragment or a composition that specifically binds to a portion of ClfA with the sequence of SEQ ID No: 15, SEQ ID NO: 16, SEQ ID NO: 17, and SEQ ID NO: 18.
Abstract translation:本发明提供了使用单克隆抗体,多克隆抗体,抗原结合抗体片段或特异性结合至抗体结合抗体片段的组合物减少纤维蛋白原在格兰氏阳性细菌感染中与ClfA结合的方法和组合物 具有序列SEQ ID No:15,SEQ ID NO:16,SEQ ID NO:17和SEQ ID NO:18的部分ClfA。 p>
Abstract:
The disclosure includes a maxillofacial rehabilitation device, comprising a frame and a dynamic actuation mechanism coupled to the frame. The frame can be configured to attach the device to the head of a user. The dynamic actuation mechanism can be configured to contact the mandible of the user, receive control signals from a controller, and move the mandible of the user in the sagittal plane and the vertical plane based on the control signals.
Abstract:
An embodiment of the invention is a shape memory polymer (SMP) foam designed to recover its original shape through exposure to a solvent. Thermo-responsive SMPs are polymers designed to maintain a programmed secondary shape until heated above their transition temperature, upon which the polymer recovers its original, or primary, shape. The thermo-responsive SMP foam is programmed to its secondary shape prior to use, typically compression of the foam to a small volume, and remains in this programmed shape until exposed to a selected solvent such as dimethyl sulfoxide or ethyl alcohol. Upon exposure to the solvent, the transition temperature of the SMP foam decreases below the temperature of the environment and the SMP foam actuates to its primary shape. The SMP foam is tailored to actuate upon exposure to specific solvents while minimizing or preventing actuation when exposed to water or other solvents. This selective solvent actuation can be used to increase working time of a SMP foam device, that is, the time allowed for use of a device without undesired actuation, while maintaining functional SMP actuation. Solvent actuated SMP foams can be used in various applications including, but not limited to, treatment of aneurysms and arterio-venous malformations, tissue engineering, and wound healing.
Abstract:
The present invention provides a biodegradable "precision polymer system" (poly system) and methods for preparing pharmaceutically effective "precision polymer nanosystems" (polymer nanosystem) for delivery and/or targeting of drugs or drug like compounds.
Abstract:
A method includes coating a substrate to provide a flame resistant substrate. In an embodiment, the method includes exposing the substrate to a cationic solution to produce a cationic layer deposited on the substrate. The cationic solution comprises cationic materials. The cationic materials comprise a melamine. The method further includes exposing the cationic layer to an anionic solution to produce an anionic layer deposited on the cationic layer to produce a layer comprising the anionic layer and the cationic layer. The anionic solution comprises a phosphated molecule.
Abstract:
A method includes coating a substrate to provide a flame resistant substrate. In an embodiment, the method includes preparing an aqueous solution. The aqueous solution comprises a phosphate material, a cationic material, and a water. The method further includes exposing the substrate to the aqueous solution to produce a coating on the substrate. The coating includes the cationic material and the phosphate material. The method also includes exposing the coating on the substrate to a melamine solution.
Abstract:
The disclosure provides a method for cleaning an implanted medical device. In one embodiment, the method includes providing a medical device including a membrane; wherein the membrane comprises a thermoresponsive hydrogel including N-isopropylacrylamide (NIPAAm) or poly(N-isopropylacrylamide) (PNIPAAm), and a volume phase transition temperature (VPTT). The method also includes implanting the medical device into a target area; wherein the membrane temperature is maintained at substantially the same temperature as the target area; wherein temperature fluctuations within the target area that approach, meet and/or exceed the volume phase transition temperature induce deswelling or relative deswelling in the membrane and temperature fluctuations within the target area that are relatively lower and/or approach and/or fall below the volume phase transition temperature induce swelling or relative swelling in the membrane.
Abstract:
A rubber substrate has a material diffusion barrier, and a method produces the same. In an embodiment, a method for producing a material diffusion barrier on a rubber substrate includes exposing the rubber substrate to a cationic solution to produce a cationic layer on the rubber substrate. The method also includes exposing the cationic layer to an anionic solution 5 to produce an anionic layer on the cationic layer. The anionic layer comprises graphene oxide. The layer includes the cationic layer and the anionic layer. The layer comprises the material diffusion barrier.
Abstract:
Activated iron media and methods for generating and usmg the activated iron media. The method involves aqueous suspension comprising a zero-valent iron, ferrous iron, and an iron oxide to provide a settled solid and re-suspending the settled solid to provide an aqueous suspension containing an activated iron media.
Abstract:
A hybrid activated iron-biological treatment system and method for treating wastewater. The treatment system includes a combination of zero valent iron, ferrous iron, an iron oxide, and a denitrification microorganism.